Table 3: Medication related and life style related characteristics among T2DM patient’s in Mettu Karl Referral Hospital, South-western, Ethiopia, 2021.
Variables |
Category |
Frequency |
Percent |
Duration of treatment |
1-4 years |
62 |
50.8 |
5-10 years |
43 |
35.2 |
|
> 10 years |
17 |
13.9 |
|
Drug regimen |
Oral hypoglycemic agents |
87 |
71.3 |
Oral hypoglycemic agents + Insulin |
35 |
28.7 |
|
Type of DM drugs |
Metformin |
41 |
33.6 |
Glibenclamide and metformin |
19 |
15.6 |
|
Glibenclamide |
17 |
13.9 |
|
Metformin and NPH insulin |
34 |
27.9 |
|
Metformin + Glibenclamide + insulin |
11 |
9.0 |
|
Numbers of drugs taken |
≤ 2 drugs |
77 |
63.1 |
> 2 drugs |
45 |
36.9 |
|
Concomitant medication |
Yes |
50 |
41.0 |
No |
72 |
59.0 |
|
Type of concomitant medication |
Enalapril |
21 |
42.0 |
Enalapril + ASA |
16 |
32.0 |
|
Enalapril + ASA + atenolol |
9 |
18.0 |
|
Enalapril + ASA + hydrochlorothiazide |
4 |
8.0 |
|
Health diet |
Adequate |
56 |
45.9 |
Inadequate |
66 |
54.1 |
|
Physical exercise |
Yes |
43 |
35.2 |
No |
79 |
64.8 |
|
Foot care |
Yes |
27 |
22.1 |
No |
95 |
77.9 |
|
Self-monitoring blood glucose |
Yes |
35 |
28.7 |
No |
87 |
71.3 |